Menu menu
  • Flux RSS
  • Twitter
  • Facebook
  • Google Plus
  • LinkedIn
Newsletter - April 2016

Newsletter - April 2016

Read our latest newsletter → Visit the (...)

Genopole's Business Support

Genopole’s Business Support

The leading biotech and biotherapy cluster

The leading biotech and biotherapy cluster

Synthetic and systems biology

Synthetic and systems biology

Our real estate offer

Our real estate offer

A medical environment

A medical environment

All Videos of Biomaths Conference

All Videos of Biomaths Conference

Genobiomedecine, a path toward personalized treatments

Genobiomedecine, a path toward personalized treatments

Agenda

08.09

BIOREGATE. European Regenerative Medicine Forum

Bioregate Forum is a great opportunity to present and discuss your company’s or organisation’s latest achievements in research, innovation, clinical trials or market access approaches. The (...)

Read more

27.06

WIN 2016 Symposium

“Innovative Approaches to Improve Cancer Patient Outcomes” It is the 8th edition of a successful series of symposia organized by the Worldwide Innovative Networking (WIN) Consortium, dedicated to (...)

Read more

12.06

International Congress on Personalized Health Care

Personalized Health Care: From Research to Impact Palais des Congrès de Montréal At the dawn of the twenty-first century, the most recent research in molecular biology, advances in genomics, and (...)

Read more

Live news

  • Genopole

    3 May 2016

    Accord Texcell /ATRI: une offre de services de sécurité virale pour l'Extrême Orient https://t.co/W258AeTJhG https://t.co/AM4NtHIY6w

  • Genopole

    3 May 2016

    First gene therapy successful against human aging https://t.co/ZwbpfdnmjR

  • Genopole

    3 May 2016

    Scientists Successfully Genetically Modify Human Embryos Against HIV https://t.co/vnFEUOBlzV

  • Genopole

    3 May 2016

    RT @PLOSSynbio: @IONIS_iGEM + @iGEM_Evry are hosting a #synbio meetup + party for #iGEM2016 teams! sign up https://t.co/vsPAhTMA44 https:/…

  • Genopole

    3 May 2016

    New breast cancer genes may inform future treatment https://t.co/LCaPdq0HeQ

  • Genopole

    3 May 2016

    CRISPR: entre peur et euphorie, la bataille de l'éthique bat son plein https://t.co/d437nsFUZU via @upmagazine_info

  • Genopole

    3 May 2016

    Cancer du sein: 93 mutations génétiques: l'analyse des signatures de mutation va commencer ! https://t.co/qu72COV354 #sante

  • Genopole

    2 May 2016

    #3-@Genopole newsletter : visit the Genopole biocluster in 3D https://t.co/1L2goXzPUQ https://t.co/JDdUsDE2Wy

  • Genopole

    2 May 2016

    RT @Inra_France: Les petits ARN:acteurs majeurs à considérer dans la #sélectionvégétale #épigénétique #Inra https://t.co/0Ml1ro8H2s https:/…

  • Genopole

    2 May 2016

    RT @BiocellT: A cool 3D tour of the Genopole biocluster near Paris and plenty of other info in their newsletter https://t.co/Hdr6joAweC

  • Genopole

    2 May 2016

    RT @destinationsant: Génome : les dessous des cancers du sein dévoilés #cancer #sein #gé https://t.co/6v41h85L2U nome https://t.co/9HyazKhT…

  • Global Bioenergies on track with the development schedule of its bio-isobutene production process

    Global Bioenergies, an industrial biology company developing sustainable routes to light olefins, announces significant progress in the development of its process for the production of biological (...)

  • Gene Signal and collaborators demonstrate successful activity of topical aganirsen

    Gene Signal announced the publication of data demonstrating the significant activity of aganirsen (GS-101, eye drop) in two important models of retinal neovascular disease, wet age-related (...)

Sharing expertise, competencies and means

Sharing expertise, competencie

Sharing expertise, competencies and means

The Infrastructures and Platforms Department (...)


Create, Develop, Attract

Create, Develop, Attract

Create, Develop, Attract

The mission of the Genopole Enterprises team (...)